ANVISA authorized brand new laws for the roll-out of medicinal items based on cannabis

The Brazilian Health Regulatory Agency (ANVISA) authorized, at the start of December 2019, regulations that enable the purchase in pharmacies of cannabis-based items for medical purposes. The procedures for manufacturing and importing such products and the requirements for prescription, sale, and supervision are approved in these new proposals. Authorization will not consist of substance managing in pharmacies and it is just permitted to offer – by prescription – services and products already developed straight through the maker. […]